Pharma & Biotech News #PharmaBuzz

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Weekly News Recap #Phispers

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

In Phispers this week, the US Food and Drug Administration (FDA) approved AstraZeneca’s first-in-class treatment for hype...

Impressions : 1840

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

The US Food and Drug Administration (FDA) has seen several high profile exits under the Trump Administration. The most high pro...

Impressions : 1504

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

In Phispers this week, India’s Intas Pharmaceuticals received a warning letter from the US Food and Drug Administration (...

Impressions : 1919

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

In Phispers this week, Indian drugmaker Sun Pharmaceutical acquired Jersey-based Organon in an all-cash deal valued at about US...

Impressions : 1804

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

Actavis's Generics Linaclotide Receives Tentative Approval in US

Aspiro's Generics Isoproterenol HCl Receives Approval in US

Quagen's Generics Glycopyrrolate Receives Approval in US

Jubilant Generics' Generics Tadalafil Receives Approval in US

Ascent's Generics Clomiphene Citrate Receives Approval in US

Zydus' Generics Ammonium Lactate Receives Approval in US

Dr Reddy's Generics Phytonadione Receives Approval in US

Dr Reddy's Generics Venetoclax Receives Approval in US

Astrazeneca Pharms' Baxfendy Receives Approval in US

Ionetix's Generics Gallium Gozetotide Receives Approval in US

Enforcement Report - Week of May 20, 2026

Hangzhou Yiqi Biotechnology's Receives FDA Warning Letter

Naseem A Jaffrani's Receives FDA Warning Letter

Sourav K Mishra's Receives FDA Warning Letter

JW Nutritional's Receives FDA Warning Letter

Best Supplements Recalls WAP Capsules for Undeclared Active Drugs

Enforcement Report - Week of May 13, 2026

Sun Pharma Recalls Doxorubicin Injection Over Glass Particle Risk

Pharmacal Issues Nationwide Recall of MG217 Eczema Cream

Mukesh B Chandre's Receives FDA Warning Letter

Shreevar Kheruka Appointed Managing Director At Borosil Limited

Fortis Healthcare FY26 Revenue Crosses Rs. 9,100 Crore

Alembic Gets USFDA Nod For Generic Levothyroxine Sodium Tablets

Gilead's Hepcludex is first FDA-approved treatment for HDV

LIR, Neuland Launch Phase 1 Transdermal Delivery System Trial

Lupin Enters China Market with Approval for Oseltamivir

OSE Turn Up Heat on Ovarian Cancer With Ph2 Win, Support Keytruda

European Commission Approves Joenja for APDS in EU

Recordati fields $12.4B go-private offer

Venus Remedies receives Saudi FDA approval for Plerixafor

Alembic Gets USFDA Nod For Generic Levothyroxine Sodium Tablets

Lupin Enters China Market with Approval for Oseltamivir

Jubilant Pharmova Posts FY26 Revenue Of Rs. 8,280 Crore, Up 14%

Takeda Pharma Ordered To Pay $2.5 Billion In Amitiza Case

Sunshine Biopharma Gets Canadian OK for Generic Amoxicillin

MedExpress Canada Launches Generic Semaglutide At $124.99

Shaily Launches Combo Product with ShailyPen Neo Technology

Dr Reddy's launches oral semaglutide biosimilar Obeda in India

Lupin Gets Tentative FDA Approval for Revefenacin Inhalation

BioSyent Gets Health Canada OK for Thyconvi Levothyroxine

Gilead's Hepcludex is first FDA-approved treatment for HDV

LIR, Neuland Launch Phase 1 Transdermal Delivery System Trial

OSE Turn Up Heat on Ovarian Cancer With Ph2 Win, Support Keytruda

European Commission Approves Joenja for APDS in EU

Recordati fields $12.4B go-private offer

Otarmeni Receives EMA Filing Acceptance for Genetic Hearing Loss

Foundation Medicine Showcases Innovation at ASCO Annual Meeting

FDA Panel Reviews Moderna's mRNA Flu Shot The headline is already

Calidi Biotherapeutics Provides Required NYSE American Disclosure

Astegolimab Reduces COPD Exacerbations In Large Pooled Analysis

Why Choosing the Right Mupirocin Calcium Manufacturer Matters

Gilead Inks $140M Deal With Korean API Maker Yuhan

Curia Completes API Aseptic Suite Upgrade in Valladolid, Spain

BioNxt Advances Semaglutide ODF into Active Pharma Development

Bulk Drugs And Intermediates Exports Grew 3.76% In FY26

Drugmakers Battle Rising Costs, Export Slump

How HRV Pharma Is Redefining Pharma Value Creation

Provectus Reports PV-10 Clears Tumors in Bladder Cancer Survivors

Piramal Pharma, Botanix Partner on Drug Substance Development

Imports Of Bulk Drugs Decline 3.31 Per Cent In FY26

Centre Moves Pregabalin To Schedule H1 To Combat Drug Misuse

CDSCO Urges Public to Report Cosmetic Violations

Lilly Accuses Church Pharmacies of $200M Rebate Fraud

FDA Issues Warning Letter Over Chinese Supplier's GLP-1 Import

No Cosmetic Job With Jabs, Warns Drug Regulator CDSCO

India Well-Positioned to Push Back Quality Perception Battle

IPC Reports Rising ADRs Linked to Antidepressants in India

CDSCO Targets Violations in GLP-1 Weight Loss Drug Sales

CDSCO Cannot Prosecute Pharma Under D&C Act: Himachal HC

FDA Warns Researchers and Drugmakers for Clinical, GMP Violations

World Health Assembly Endorses Resolution On Precision Medicine

Congo Province Bans Funeral Wakes To Contain Ebola's Spread

Bundibugyo Ebola: Vaccines and Treatments in Development